Gain new perspectives for faster progress directly to your inbox.
![PEGylated-Journal-Hero-1920x1080](/sites/default/files/styles/insights_index_hero/public/images/PEGylated-Journal-Hero-1920x1080.jpg?h=d1cb525d&itok=joF5QdJD)
Lipid nanoparticles have redefined what’s possible in drug delivery, from recent acclaim in COVID-19 vaccines to a storied history of novel drug delivery mechanisms. However, it may come with a price: immune reactions that can compromise the safety and efficacy of PEGylated lipid nanoparticles. With a clinical pipeline full of exciting new RNA therapeutics, how can we overcome this? Learn more about the emerging trends, opportunities, and challenges in our latest peer-reviewed publication in Bioconjugate Chemistry.